WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Storms damage homes in Oklahoma and Kansas. But in Houston, most power is restored
Chasing perfection in Paris preparations
Enterprises bullish on supply chain expo
Company Law draft revision to bolster confidence
Everybody may love Raymond, but Ray Romano loves Peter Boyle
Xi Story: A Champion of Closer People
Surfers converge on Hainan for championships
Chinese paddlers Wang, Sun lift trophies at WTT Cup Finals
Amtrak train hits pickup truck in upstate New York, 3 dead including child
Team China braced for tough challenge